Spots Global Cancer Trial Database for Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
Official Title: Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
Study ID: NCT05392374
Conditions
Interventions
Study Description
Brief Summary: This is an intermediate-size expanded access protocol to provide ONC201 to patients with diffuse intrinsic pontine gliomas who cannot access ONC201 through clinical trials.
Detailed Description:
Keywords
Eligibility
Minimum Age: 6 Months
Eligible Ages: CHILD, ADULT
Sex:
Healthy Volunteers: No
Locations
University of California San Francisco, San Francisco, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Children's National Medical Center, Washington, District of Columbia, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
University of Michigan, Ann Arbor, Michigan, United States
University of Nebraska Medical Center, Omaha, Nebraska, United States
Albany Medical Center, Albany, New York, United States
NYU Langone Health, New York, New York, United States
Stephen Hassenfeld Children's Center for Cancer and Blood Disorders (NYU), New York, New York, United States
University of Rochester Medical Center, Rochester, New York, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
